#27 – David Sinclair, Ph.D.: Slowing aging – sirtuins, NAD, and the epigenetics of aging
- Guest
- David Sinclair
- Read time
- ~4 min
- Uploaded
- 6 Jan 2020
- Duration
- 1:41:32
- Views
- 29.0K
KEYPOINTS
- 01
Sirtuins came from an unbiased genetic hunt in yeast
In Lenny Guarente's MIT lab, gene screens for yeast lifespan turned up SIR genes ('silent information regulators'), not the DNA-repair or antioxidant genes the field expected. Sir2, which has counterparts in mammals, controls gene silencing. Sinclair notes that at the time aging was blamed mainly on DNA damage and free radicals, so a gene-silencing protein was a surprise.
- 02
Sirtuins move to repair damage and neglect their usual jobs
Sinclair and student Kevin Mills stained the proteins and saw them relocate to the nucleolus, home of the ribosomal DNA, during normal aging and during an accelerated form of aging. His lab and others then showed that sirtuins were both necessary and sufficient to mimic calorie restriction in yeast and mammals. Knocking them out weakens the lifespan benefit, though Sinclair concedes that intense stress can bypass them in yeast.
- 03
NAD fuels sirtuins, and nicotinamide brakes them
Sirtuins consume NAD and release nicotinamide (a form of vitamin B3). When his first student, Kevin Bitterman, fed yeast nicotinamide expecting activation, he got inhibition. Sinclair explains it as a negative feedback pocket in the enzyme that senses its own by-product, and says he wouldn't recommend very high doses of nicotinamide. Labs worldwide now use it as a sirtuin inhibitor.
- 04
Calorie restriction switches on NAD recycling
PNC1, an NAD-salvage gene previously studied in tuberculosis, was among the most strongly upregulated genes in calorie-restricted yeast. That connected nutrient stress to higher sirtuin activity through NAD.
- 05
Resveratrol was a proof-of-concept activator, not a drug
In 2003, Konrad Howitz at Biomol screened compounds and found plant molecules that appeared to activate human SIRT1. The two labs spent about six months trying to disprove it, because true allosteric activators are rare. What convinced Sinclair was that the molecules extended yeast lifespan only when the sirtuin gene was present. Even so, he calls resveratrol 'a terrible molecule' because it dissolves so poorly.
- 06
Mouse results depended on diet and absorption
In his 2006 study, middle-aged mice on a high-fat, high-sugar 'Western' diet given resveratrol (about 200 mg/kg/day, by his recollection) lived roughly 20–25% longer than equally fed controls. The NIA's Interventions Testing Program later found no lifespan extension with resveratrol mixed into standard chow, which Sinclair says matches his own data and reflects absorption. He says fat improved blood levels in his studies, so he takes it with oil or yogurt.
- 07
His personal regimen comes with explicit uncertainty
Sinclair takes about a gram of resveratrol, reasoning that if it doesn't work at a gram it won't work at more. He also takes metformin at a low dose because the pathways overlap and stacking compounds is 'unknown territory', plus NMN. He doubts resveratrol will add even five years to his life, but believes it may delay cardiovascular disease.
- 08
Aging as loss of analog information
Sinclair previewed an unpublished 'unifying theory'. DNA is digital and stays largely intact in old animals, he says, while the epigenetic pattern of which genes are switched on is analog and degrades like a scratched CD. Using Waddington's 1950s landscape, he describes cells as marbles jostled out of their valleys until neurons and liver cells lose their identity. His lab was writing up experiments in which manipulating the epigenome produces hallmarks of aging.
- 09
Old eggs may suffer from low NAD
Sinclair links egg aneuploidy to faulty spindles. He describes a kinase that controls spindle quality, regulated by the NAD-dependent sirtuin SIRT2, and says giving NAD precursors to older mice produced healthier, more numerous eggs. Whether this applies to sperm is untested. This is mouse work, not a human fertility treatment.
EXAMPLES
- 01
The 10-gram resveratrol trials
Worried about poor absorption, clinical researchers dosed people at about 10 grams a day. A couple of late-stage cancer patients developed kidney failure, which Sinclair notes happens anyway in such patients, but the company decided it wasn't worth pursuing for a would-be blockbuster.
- 02
Starting at the equivalent of age 70
Sinclair says unpublished work from his lab extends mouse lifespan even when treatment begins after 600 days, roughly 70% of the way through life, and hinted that NMN given in drinking water to normal mice was involved.
- 03
The 5,000-person trial he'd fund
With unlimited money, Sinclair would give metformin, rapalogs or NAD precursors to about 5,000 people in their 70s for three to four years and look for a change in the mortality hazard ratio. He puts the cost in the tens of millions against potential savings in the trillions. Attia compares the design to Nir Barzilai's metformin (TAME) trial, which focuses more on healthspan.
- 04
A grandmother who never lied
Sinclair traces his focus on mortality to his grandmother Vera (who insisted on being called by her first name) answering his childhood question honestly: everyone he loved, his cat and he himself would die. He notes that children typically grasp death between four and seven, then bury the thought until around 50.
OTHER RELEVANT
- 01
Products using Sinclair's name aren't endorsed by him
He says nothing sold over the counter carries his name with his or Harvard's permission, and that he has sent many cease-and-desist letters. Be skeptical of supplements marketed with his name.
- 02
Don't megadose B3 to boost NAD
Because nicotinamide inhibits sirtuins through feedback, Sinclair advises against very high doses. Precursors like NR and NMN, he says, are still early, and we don't yet know which tissues take them up preferentially.
- 03
Introduce compounds one at a time
Following Sinclair's caution about overlapping pathways, if you combine metformin, resveratrol or NAD precursors with your doctor's oversight, start low and add one thing at a time rather than stacking full doses.